ATE241630T1 - Verfahren zur herstellung von ucn-01 - Google Patents

Verfahren zur herstellung von ucn-01

Info

Publication number
ATE241630T1
ATE241630T1 AT99125341T AT99125341T ATE241630T1 AT E241630 T1 ATE241630 T1 AT E241630T1 AT 99125341 T AT99125341 T AT 99125341T AT 99125341 T AT99125341 T AT 99125341T AT E241630 T1 ATE241630 T1 AT E241630T1
Authority
AT
Austria
Prior art keywords
ucn
producing
acidified
producing ucn
solution
Prior art date
Application number
AT99125341T
Other languages
German (de)
English (en)
Inventor
Akihito Nagamura
Hidenori Aoki
Mitsutaka Kino
Toshimitsu Takiguchi
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Application granted granted Critical
Publication of ATE241630T1 publication Critical patent/ATE241630T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT99125341T 1998-12-22 1999-12-21 Verfahren zur herstellung von ucn-01 ATE241630T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10364369A JP2000186092A (ja) 1998-12-22 1998-12-22 Ucn−01の製造法

Publications (1)

Publication Number Publication Date
ATE241630T1 true ATE241630T1 (de) 2003-06-15

Family

ID=18481646

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99125341T ATE241630T1 (de) 1998-12-22 1999-12-21 Verfahren zur herstellung von ucn-01

Country Status (6)

Country Link
US (1) US6197955B1 (https=)
EP (1) EP1020471B1 (https=)
JP (1) JP2000186092A (https=)
AT (1) ATE241630T1 (https=)
CA (1) CA2293023A1 (https=)
DE (1) DE69908288T2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6887864B2 (en) 2002-03-12 2005-05-03 Hoffmann-La Roche Inc. Azepane derivatives
PL2256106T3 (pl) 2003-07-22 2015-08-31 Astex Therapeutics Ltd Związki 3,4-pochodne 1h-pirazolu i ich zastosowanie jako kinazy zależne od cyklin (cdk) i modulatory kinazy syntazy glikogenu-3 (gsk-3)
MX2007008781A (es) * 2005-01-21 2007-09-11 Astex Therapeutics Ltd Compuestos farmaceuticos.
AR054425A1 (es) 2005-01-21 2007-06-27 Astex Therapeutics Ltd Sales de adicion de piperidin 4-il- amida de acido 4-(2,6-dicloro-benzoilamino) 1h-pirazol-3-carboxilico.
US8404718B2 (en) 2005-01-21 2013-03-26 Astex Therapeutics Limited Combinations of pyrazole kinase inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62220196A (ja) 1986-03-20 1987-09-28 Kyowa Hakko Kogyo Co Ltd 新規物質ucn―01
WO1989007105A1 (fr) 1988-02-04 1989-08-10 Kyowa Hakko Kogyo Co., Ltd. Derives de staurosporine
DE69326388T2 (de) * 1992-06-22 1999-12-30 Kyowa Hakko Kogyo Co., Ltd. Verfahren zur Herstellung von Staurosporin-Derivaten

Also Published As

Publication number Publication date
EP1020471B1 (en) 2003-05-28
US6197955B1 (en) 2001-03-06
EP1020471A1 (en) 2000-07-19
DE69908288D1 (de) 2003-07-03
DE69908288T2 (de) 2004-04-08
CA2293023A1 (en) 2000-06-22
JP2000186092A (ja) 2000-07-04

Similar Documents

Publication Publication Date Title
ATE121066T1 (de) Verfahren zur herstellung von 6,12-dihydro-6- hydroxy-cannabidiol und dessen anwendung zur herstellung von trans-delta-9- tetrahydrocannabinol.
DE69908998D1 (de) Verfahren zur Herstellung von Kohlenstoff
DE69623550D1 (de) Verfahren zur Herstellung von Graphitfasern
ATE162551T1 (de) Verfahren zur herstellung von dihomo-gamma- linolensäure und das in dieser enthaltende lipid
DE68916086D1 (de) Verfahren zur Herstellung von Kohlenstoff/Kohlenstoff-Verbundstoffen.
EP0576263A3 (en) Process for manufacturing nanostructures and nanostructure produced by this process.
ATE201025T1 (de) Verfahren zur herstellung von cephalosporinen und zwischenprodukte in diesem verfahren
DE59502202D1 (de) Verfahren zur kontinuierlichen Herstellung von hochreinem Bisphenol-A
ATE101144T1 (de) Verfahren zur herstellung von cyclischen sulfaten.
DE68922360D1 (de) Verfahren zur Herstellung von Metall-Polyimid-Verbundwerkstoffen.
DE68911810D1 (de) Verfahren zur Herstellung von Graphitblöcken.
ATE241630T1 (de) Verfahren zur herstellung von ucn-01
DE69102665D1 (de) Verfahren zur Herstellung von Katalysatoren.
DE69519799D1 (de) Verfahren zur herstellung von [s,s]-ethylendiamin-n,n'-dibernsteinsäure
DE59006645D1 (de) Verfahren zur kontinuierlichen herstellung von 3,3'-dichlor-benzidin-dihidrochlorid.
DE59101230D1 (de) Verfahren zur Herstellung von Katalysatoren.
ATE277919T1 (de) Verfahren zur herstellung von baccatin iii- derivativen
ATE101846T1 (de) Verfahren zur herstellung von 1,1dichlorotetrafluorethan.
DE69317237D1 (de) Verfahren zur Herstellung von abriebfesten, transparenten Teilen
ATE174966T1 (de) Verfahren zur herstellung von biotin
ATE132535T1 (de) Verfahren zur diskontinuierlichen herstellung von l-carnitin auf mikrobiologischem weg
ATE235461T1 (de) Verfahren zur herstellung von 3-cyano-2,4- dihalogen-5-fluor-benzoesäuren
DE59905165D1 (de) Verfahren zur Herstellung von Orthoestern
DE50105715D1 (de) Verfahren zur herstellung von dnda
DE68920358D1 (de) Verfahren zur Herstellung von Schwefelwasserstoff.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties